To test whether the inhibition of tumors is mediated by the activity of the ENTPD3's ATPase, we used the same method to eliminate or weaken the enzymatic activity of ENTPD3 in MDA-MB-231 breast cancer cells. Here, ENTPD3 is linked to breast cancer.